obesity drugs
Structure posts promising results for oral obesity drug, but delays further data due to error
Anika Sharma
Structure Therapeutics has offered an initial glimpse into the effectiveness of its oral GLP-1 receptor agonist, reporting a notable 5% ...
Novo and Lilly’s obesity drugs face barriers of high price and low coverage, survey shows
Anika Sharma
A recent survey of 100 doctors in the United States who prescribe weight loss medications has revealed that over 75% ...
